IRD
Opus Genetics, Inc. Common Stock
28 hedge funds and large institutions have $1.78M invested in Opus Genetics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
10
Reduced
4
Closed
5
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$16K
Top Buyers
1 |
Renaissance Technologies
New York
|
+$262K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$107K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$87.8K |
4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$43K |
5 |
TSS
Two Sigma Securities
New York
|
+$35K |